Provided by Goodwin Procter LLP
Goodwin’s fully integrated practice is designed to help clients navigate the rapidly evolving demands by providing a unique “one-stop-shop” service. What sets us apart is our holistic approach to our life sciences practice through the integration across deeply specialized life sciences disciplines. The team has extensive experience working with domestic and international clients to support their business operations; facilitate fundraising activities; develop, defend and enforce comprehensive patent portfolios; navigate complex regulatory environments; execute on complex corporate transactions including capital market offerings, licensing and collaboration transactions, and M&A deals; and represent innovators and generics in Hatch-Waxman litigation.
Goodwin has long been a firm that works with start-up to established public company clients throughout the corporate life-cycle. From that, we have earned a spot as one of the most active governance practices in the United States, serving as outside counsel to public companies and public company boards of directors in the life sciences industry who are listed on both U.S. and non-U.S. exchanges.
Provided by Chambers
Goodwin has broad experience advising early-stage life sciences companies on venture capital financings. strategic partnerships and IPOs. The group also houses significant patent prosecution and enforcement capability.
Goodwin Procter LLP advised Avalyn Pharma on the closing of an oversubscribed $100 million Series D financing.
Provided by Chambers
Goodwin Procter has deep experience with asset deals in biotech as well as great people with a collaborative work style.
The Goodwin team exhibits deep subject matter expertise, a practical approach and a willingness to provide guidance and opinions.
Goodwin consistently provide high quality legal services and offer a sophisticated, strategic thought partnership.
Goodwin Procter has deep experience with asset deals in biotech as well as great people with a collaborative work style.
The Goodwin team exhibits deep subject matter expertise, a practical approach and a willingness to provide guidance and opinions.
Goodwin consistently provide high quality legal services and offer a sophisticated, strategic thought partnership.
Provided by Chambers
Kingsley Taft cochairs Goodwin's global life sciences practice. He is frequently called upon by life sciences companies to advise on a broad range of corporate matters, including financings, IPOs and M&A.
Mitchell Bloom co-chairs the firm's global life sciences group and is frequently called upon by emerging and established life sciences companies for counseling on a range of matters, including M&A, IPOs and financings.
Mitch provides outstanding counsel. Directors and C-suite executives find his work to be of exceptionally high quality.
Stuart Cable offers substantial experience of advising life sciences companies of all sizes on key matters, including M&A and corporate governance. Stuart is the firm's vice chair and global head of M&A.
Stuart is one of the finest M&A lawyers in the life sciences field. He brings wisdom and personal engagement.
Michael Bison advises life sciences clients on financing and international M&A and licensing transactions. He has particular expertise acting on behalf of sellers.
Michael's broad expertise, engagement of specialists, calm and measured manner, constructive guidance and ability to cut to the chase on any complex matter are simply unmatched.
Sarah Solomon is trusted by life sciences clients to advise on large multijurisdictional licensing and collaboration agreements. Her expertise extends throughout the transactional space, including royalty sales and M&A.
Sarah is great. She has clear expertise in all partnering dynamics and is good at getting things done and making herself available.
Sarah is great in negotiations and generally incredibly responsive.
Provided by Goodwin Procter LLP